SelectScience InterviewsClinical Diagnostics
8 key trends shaping the future of clinical laboratory medicine
24 Sept 2024
Duncan Porter, with 25 years of clinical diagnostics industry experience, working with companies such as Thermo Fisher Scientific and Tasso, introduces SelectScience’s CLINICAL24 program. Over the next three months, CLINICAL24 is set to highlight the day-to-day challenges facing clinical labs, and to explore the key diagnostic advancements designed to overcome them. Find out what Porter believes to be the eight major trends transforming the field. Ranging from molecular diagnostics and point-of-care, to AI and machine learning, discover how technologies and innovations are reshaping healthcare.
Become a member of SelectScience to be kept updated on activities during the CLINICAL24 program.
This video was recorded for #CLINICAL24 2024.
Tags
CLINICAL24CLINICAL24 is a global conversation, hosted by SelectScience for the medical laboratory profession and all those that support it. The purpose of CLINICAL24 is to highlight current lab challenges, and to explore the technology solutions to overcome them. MicrobiomeMicrobiome research focuses on the complex communities of microorganisms living in and on humans, animals, plants, and environments. It plays a crucial role in health, disease, and ecological balance. Explore tools and resources for microbiome analysis, including sequencing platforms and bioinformatics software.Liquid BiopsiesLiquid biopsies are non-invasive tests used to detect cancer and other diseases by analyzing blood or other bodily fluids. This technique is gaining popularity for early detection, monitoring treatment response, and detecting minimal residual disease. Explore liquid biopsy solutions in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.